Posted Two Blokes
byNEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical com
Source: Two Blokes Trading
Posted Two Blokes
byCG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohor
Source: Two Blokes Trading
Posted Two Blokes
byPRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing
Source: Two Blokes Trading
Posted Two Blokes
byBeijing has been canvassing companies and waiving duties on American goods in sectors where it lacks alternati
Source: Two Blokes Trading
Posted Two Blokes
byLong-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed f
Source: Two Blokes Trading
Posted Two Blokes
byAlphabet, Amazon, Apple, Meta, Microsoft, Nvidia and Tesla are off to their worst start since the 2022 slide,
Source: Two Blokes Trading
Posted Two Blokes
byOne-year clinical trial data for the next-generation, investigational, Sphere-360\u2122 single-shot PFA cathet
Source: Two Blokes Trading
Posted Two Blokes
byThe dream of seeing Dogecoin trade at $1 remains alive among its community of loyal investors, even as the mem
Source: Two Blokes Trading
Posted Two Blokes
byPhase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than
Source: Two Blokes Trading
Posted Two Blokes
byPhase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than
Source: Two Blokes Trading
Posted Two Blokes
byFirst results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tu
Source: Two Blokes Trading
Posted Two Blokes
byFirst results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tu
Source: Two Blokes Trading